NAFLD: mechanisms, treatments, and biomarkers
F Nassir - Biomolecules, 2022 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-associated fatty liver
disease (MAFLD), is one of the most common causes of liver diseases worldwide. NAFLD is …
disease (MAFLD), is one of the most common causes of liver diseases worldwide. NAFLD is …
Emerging role of aging in the progression of NAFLD to HCC
Y He, Y Su, C Duan, S Wang, W He, Y Zhang… - Ageing Research …, 2023 - Elsevier
With the aging of global population, the incidence of nonalcoholic fatty liver disease
(NAFLD) has surged in recent decades. NAFLD is a multifactorial disease that follows a …
(NAFLD) has surged in recent decades. NAFLD is a multifactorial disease that follows a …
Reprogramming of hepatic metabolism and microenvironment in nonalcoholic steatohepatitis
L Rui, JD Lin - Annual review of nutrition, 2022 - annualreviews.org
Nonalcoholic fatty liver disease (NAFLD), a spectrum of metabolic liver disease associated
with obesity, ranges from relatively benign hepatic steatosis to nonalcoholic steatohepatitis …
with obesity, ranges from relatively benign hepatic steatosis to nonalcoholic steatohepatitis …
Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression
M Juárez‐Fernández, N Goikoetxea‐Usandizaga… - Hepatology, 2023 - journals.lww.com
Abstract Background and Aims: Recent studies suggest that mitochondrial dysfunction
promotes progression to NASH by aggravating the gut-liver status. However, the underlying …
promotes progression to NASH by aggravating the gut-liver status. However, the underlying …
Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial
Nicotinamide riboside and pterostilbene reduces markers of h... : Hepatology Nicotinamide
riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind …
riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind …
Time-of-day defines NAD+ efficacy to treat diet-induced metabolic disease by synchronizing the hepatic clock in mice
Q Escalante-Covarrubias, L Mendoza-Viveros… - Nature …, 2023 - nature.com
The circadian clock is an endogenous time-tracking system that anticipates daily
environmental changes. Misalignment of the clock can cause obesity, which is accompanied …
environmental changes. Misalignment of the clock can cause obesity, which is accompanied …
Synthesis, Optimization, and Structure–Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs)
Depletion of nicotinamide adenine dinucleotide (NAD+) is associated with aging and
disease, spurring the study of dietary supplements to replenish NAD+. The catabolism of …
disease, spurring the study of dietary supplements to replenish NAD+. The catabolism of …
Гепатопротекторы
СВ Оковитый, ВА Приходько, НН Безбородкина… - 2022 - elibrary.ru
В настоящем издании проанализированы и систематизированы сведения по
клиническому применению лекарственных средств, для которых гепатотропное …
клиническому применению лекарственных средств, для которых гепатотропное …
Nad+ Precursors and intestinal inflammation: therapeutic insights involving gut microbiota
J Niño-Narvión, MI Rojo-López, P Martinez-Santos… - Nutrients, 2023 - mdpi.com
The oxidized form of nicotinamide adenine dinucleotide (NAD+) is a critical metabolite for
living cells. NAD+ may act either as a cofactor for many cellular reactions as well as a …
living cells. NAD+ may act either as a cofactor for many cellular reactions as well as a …
[HTML][HTML] Mitochondrial quality control: its role in metabolic dysfunction-associated steatotic liver disease (MASLD)
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-
alcoholic fatty liver disease, is characterized by hepatic steatosis and metabolic dysfunction …
alcoholic fatty liver disease, is characterized by hepatic steatosis and metabolic dysfunction …